Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.
Liu, Yao-Chung
Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report. [electronic resource] - Journal of medical case reports Mar 2020 - 43 p. digital
Publication Type: Case Reports; Journal Article
1752-1947
10.1186/s13256-020-02363-3 doi
Adult
Allografts--drug effects
Aminopterin--analogs & derivatives
Hematopoietic Stem Cell Transplantation
Humans
Lymphoma, Extranodal NK-T-Cell--therapy
Male
Neoplasm Staging
Remission Induction
Taiwan--epidemiology
Transplantation Conditioning
Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report. [electronic resource] - Journal of medical case reports Mar 2020 - 43 p. digital
Publication Type: Case Reports; Journal Article
1752-1947
10.1186/s13256-020-02363-3 doi
Adult
Allografts--drug effects
Aminopterin--analogs & derivatives
Hematopoietic Stem Cell Transplantation
Humans
Lymphoma, Extranodal NK-T-Cell--therapy
Male
Neoplasm Staging
Remission Induction
Taiwan--epidemiology
Transplantation Conditioning